Position in AVXL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$137,707
+$137,707 QoQ
Shares Held
44,856
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Derivatives in AVXL
reported options exposure · as of Dec 31, 2025CallValue
$160,200
CallShares
45,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. AVXL ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in AVXL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $137,707 | 44,856 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $160,200 | 45,000 | Call | Defined | 2026-02-17 | |
| 2024-12-31 | $1,129,096 | 105,130 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $246,258 | 58,355 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $354,355 | 69,618 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $497,656 | 53,454 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $213,143 | 32,541 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $366,695 | 45,104 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $427,719 | 46,190 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,138,817 | 304,149 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,777,313 | 377,354 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,808,615 | 309,392 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $286,595 | 16,528 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $805,578 | 44,879 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,278,981 | 99,693 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $769,162 | 51,449 | Shares | Defined | 2021-05-17 | |
| 2020-06-30 | $153,479 | 31,195 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $191,387 | 60,758 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||